Advertisement

Advertisement

LUCD Stock Latest News

Lucid Diagnostics Earnings Call Balances Progress and Risk

Company AnnouncementsLucid Diagnostics Earnings Call Balances Progress and Risk

Analyst Reaffirms Buy on Lucid Diagnostics, Sees Upside to $2.50 Target on Coverage Momentum and Validated EsoGuard Utility

PremiumRatings

Analyst Reaffirms Buy on Lucid Diagnostics, Sees Upside to $2.50 Target on Coverage Momentum and Validated EsoGuard Utility

7d ago

Lucid Diagnostics reports Q2 non-GAAP EPS (6c), consensus (5c)

PremiumThe Fly

Lucid Diagnostics reports Q2 non-GAAP EPS (6c), consensus (5c)

7d ago

Lucid Diagnostics Reports Q2 Growth Ahead of Medicare Decision

PremiumCompany Announcements

Lucid Diagnostics Reports Q2 Growth Ahead of Medicare Decision

11d ago

Is LUCD a Buy, Before Earnings?

PremiumPre-Earnings

Is LUCD a Buy, Before Earnings?

13d ago

Lucid announces Concert issued positive coverage policy for EsoGuard test

PremiumThe FlyLucid announces Concert issued positive coverage policy for EsoGuard test

19d ago

Lucid Diagnostics Shareholders Approve Stock Authorization Increase

Company Announcements

Lucid Diagnostics Shareholders Approve Stock Authorization Increase

2M ago

Lucid Diagnostics price target lowered to $2 from $3 at Maxim

The Fly

Lucid Diagnostics price target lowered to $2 from $3 at Maxim

3M ago

Analyst Reiterates Buy on Lucid, Maintains $2.50 Price Target Ahead of Potential Medicare Catalyst

PremiumRatings

Analyst Reiterates Buy on Lucid, Maintains $2.50 Price Target Ahead of Potential Medicare Catalyst

3M ago

Lucid Diagnostics Earnings Call Balances Progress, Pressure

PremiumCompany Announcements

Lucid Diagnostics Earnings Call Balances Progress, Pressure

3M ago

Lucid Diagnostics reports Q1 adjusted EPS (7c), consensus (6c)

PremiumThe Fly

Lucid Diagnostics reports Q1 adjusted EPS (7c), consensus (6c)

3M ago

Buy Rating Reaffirmed on Lucid Diagnostics as Medicare Coverage Prospects Support Unchanged $3 Price Target

PremiumRatings

Buy Rating Reaffirmed on Lucid Diagnostics as Medicare Coverage Prospects Support Unchanged $3 Price Target

3M ago

Lucid Diagnostics Reports Q1 2026 Results and Outlook

PremiumCompany AnnouncementsLucid Diagnostics Reports Q1 2026 Results and Outlook

3M ago

LUCD Earnings this Week: How Will it Perform?

Pre-Earnings

LUCD Earnings this Week: How Will it Perform?

3M ago

Lucid Diagnostics Raises Capital Through Direct Share Offering

Company Announcements

Lucid Diagnostics Raises Capital Through Direct Share Offering

4M ago

Lucid Diagnostics Prices $18 Million Public Equity Offering

PremiumCompany Announcements

Lucid Diagnostics Prices $18 Million Public Equity Offering

4M ago

Lucid Diagnostics prices 18M shares at $1.00 in registered direct offering

PremiumThe Fly

Lucid Diagnostics prices 18M shares at $1.00 in registered direct offering

4M ago

Lucid Diagnostics: Advancing EsoGuard Volume Growth and Reimbursement Visibility Supports Buy Rating

PremiumRatings

Lucid Diagnostics: Advancing EsoGuard Volume Growth and Reimbursement Visibility Supports Buy Rating

4M ago

Lucid Diagnostics price target raised to $9 from $8.25 at Ascendiant

PremiumThe Fly

Lucid Diagnostics price target raised to $9 from $8.25 at Ascendiant

5M ago

Lucid Diagnostics’ Earnings Call: Momentum Amid Cash Strain

PremiumCompany AnnouncementsLucid Diagnostics’ Earnings Call: Momentum Amid Cash Strain

5M ago

Is LUCD a Buy, Before Earnings?

Pre-Earnings

Is LUCD a Buy, Before Earnings?

5M ago

Lucid Diagnostics Reports Q4 2025 Results, Highlights VA Contract

Company Announcements

Lucid Diagnostics Reports Q4 2025 Results, Highlights VA Contract

5M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >